We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




AI Mammography Tools Detect Early Breast Cancer Signs Years Before Diagnosis

By HospiMedica International staff writers
Posted on 12 Jun 2026

Breast cancer screening aims to detect tumors before symptoms develop, but subtle mammographic changes can appear years before diagnosis and may be missed during routine reads. More...

Delayed detection can lead to more intensive treatment and poorer outcomes for patients and health systems. To help address this challenge, researchers evaluated whether commercially available radiology artificial intelligence (AI) can identify early warning signals in standard screening images and provide advance alerts of future breast cancer.

The investigation assessed three commercially available radiology AI-based computer‑assisted detection systems (AI‑CAD) on mammograms from the Validation of Artificial Intelligence for Breast Imaging (VAI‑B) database. The research team at Karolinska University Hospital in Stockholm conducted a retrospective analysis spanning January 2008 to April 2019. The dataset comprised 88,963 mammograms from 31,394 individuals across four regions of Sweden. In the national screening program, women aged 40 to 74 are invited for examinations every two years, and each mammogram is traditionally double‑read by two radiologists.

Each AI‑CAD system generated a cancer prediction score from prior mammograms. On average, scores were elevated among individuals who were later diagnosed with breast cancer and remained low among those who stayed cancer‑free. Approximately 20% of breast cancer cases demonstrated mammographic signs that were already visible to AI around six years before diagnosis.

When performance was set to 90% specificity, the systems identified early signs at progressively higher rates as the diagnosis approached. They flagged up to 19.7% of individuals six years before recorded diagnosis, up to 25.2% four years before, and up to 39.3% two years before. Across the study period, radiologist readers diagnosed cancer in 12,072 participants, representing 38.5% of the cohort.

The authors note that AI‑CAD scores could support radiologists in spotting nascent mammographic changes and, with a personalized interpretation of score trajectories, help determine who might benefit from closer vigilance. The study was published in Radiology, a journal of the Radiological Society of North America (RSNA), under the title “Artificial Intelligence Detection Scores in Screening Mammography for Early Breast Cancer Alerts.” The findings add to evidence that AI may complement established double‑reading workflows within organized screening programs.

Related Links
Karolinska University Hospital
RSNA


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Monitor/Defibrillator
Zenix
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: FDA clearance of multiFiltratePRO and approval of dedicated solutions expand continuous kidney replacement therapy options for U.S. patients with acute kidney injury. (Photo courtesy of Fresenius Medical Care)

U.S. Launch Expands Kidney Replacement Therapy Options With Integrated Anticoagulation

Critically ill patients with acute kidney injury often require continuous kidney replacement therapy in intensive care units. During these extracorporeal treatments, careful anticoagulation management... Read more

Surgical Techniques

view channel
Image: The LUCID prototype, which combines a miniature ultrasound device with a fluid-delivery tube, an osmotic pump and custom electronics. A coin provides a sense of scale. The system is designed to deliver substances directly into brain tissue and uses ultrasound to help them spread. (Photo courtesy of MIT)

Implantable Ultrasound Device Enhances Local Drug Delivery in Glioblastoma

Glioblastoma is an aggressive brain tumor that frequently recurs after surgery. Although surgeons can remove visible tumor tissue, residual cancer cells may remain in surrounding brain tissue and contribute... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.